Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3779 publications

Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary Endpoints From the EMBARK Trial.

Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary Endpoints From the EMBARK Trial.

Journal: The Journal of urology
Published: December 09, 2025

Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary Endpoints.

Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary Endpoints.

Journal: The Journal of urology
Published: December 05, 2025

The Ethics of Gender-Affirming Care: An Evaluation of the Research.

The Ethics of Gender-Affirming Care: An Evaluation of the Research.

Journal: The Linacre quarterly
Published: November 21, 2025

Clinical Effectiveness of Oral Relugolix in Advanced Prostate Cancer: A Structured Review of Current Primary Research.

Clinical Effectiveness of Oral Relugolix in Advanced Prostate Cancer: A Structured Review of Current Primary Research.

Journal: Cureus
Published: November 19, 2025

Upconverting Nanoparticle-Loaded Microneedles for Near-Infrared Responsive Delivery of Gonadotropins to Increase Success of In Vitro Fertilization.

Upconverting Nanoparticle-Loaded Microneedles for Near-Infrared Responsive Delivery of Gonadotropins to Increase Success of In Vitro Fertilization.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: October 24, 2025

Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer.

Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer.

Journal: The New England journal of medicine
Published: October 22, 2025

Correction to: The Effect of Leuprolide Acetate 11.25 mg 3-Month Formulation in Children with Central Precocious Puberty: A Systematic Review and Meta-analysis.

Correction to: The Effect of Leuprolide Acetate 11.25 mg 3-Month Formulation in Children with Central Precocious Puberty: A Systematic Review and Meta-analysis.

Journal: Advances in therapy
Published: October 08, 2025

A Case of Aggressive Angiomyxoma Completely Resected with Organ Preservation by Preoperative Hormone Therapy

A Case of Aggressive Angiomyxoma Completely Resected with Organ Preservation by Preoperative Hormone Therapy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: October 06, 2025

Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings.

Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings.

Journal: The American journal of psychiatry
Published: October 01, 2025

Peripheral Precocious Puberty Due to Autonomous Gonadal Activation: A Multicenter Experience.

Peripheral Precocious Puberty Due to Autonomous Gonadal Activation: A Multicenter Experience.

Journal: Cureus
Published: September 13, 2025

Therapeutic impact of leuprorelin acetate on spinal and bulbar muscular atrophy: pre- and post-marketing observational study.

Therapeutic impact of leuprorelin acetate on spinal and bulbar muscular atrophy: pre- and post-marketing observational study.

Journal: Journal of neurology
Published: September 13, 2025

Chemoselective sulfonyl fluoride exchange (SuFEx)-induced macrocyclization of tyrosine-containing peptides in aqueous media.

Chemoselective sulfonyl fluoride exchange (SuFEx)-induced macrocyclization of tyrosine-containing peptides in aqueous media.

Journal: Chemical science
Published: September 10, 2025
Showing 1-12 of 3,779

Last Updated: 01/07/2026